Shengda Bio-pharm discloses progress of synthetic biology R&D for D-Biotin

Zhejiang Shengda Bio-pharm Co., Ltd. (Shengda Bio-pharm) has established a synthetic biology platform for bacterial strain construction, high-throughput screening and fermentation, according to its disclosure made on 27 Dec., 2023 through the investo...

Vitamins China E-News 202401

www.cnchemicals.com